Nairobi — UK drugmaker GlaxoSmithKline Limited (GSK) has rebranded to Haleon Kenya Limited, effective March 14, 2025.
The rebrand comes after GSK transferred its consumer health business to Haleon to focus on innovative drugs.
Haleon will now encompass consumer health brands including Sensodyne, Panadol, Eno, and Scott’s Emulsion.
“This transition represents more than just a name change; it’s a reaffirmation of our commitment to delivering high-quality, science-driven health solutions tailored…
Read more on AllAfrica.com
South Africa Today Africa – East Africa Kenya News